Sage Journals: Discover world-class research

Retricted access

Research article

First published 2021-10

Brentuximab vedotin in real life,a seven year experience in patients with refractory/relapsed CD30+ T cell lymphoma

Lucie Oberic, Faustine Delzor, Caroline Protin [...]

Journal of Oncology Pharmacy Practice

Open access

Review article

First published 2011

Current and Emerging Therapies in Peripheral T-cell Lymphoma: Focus on Pralatrexate

Thanyanan Reungwetwattana, Sylvia Jaramillo, Julian R. Molina

Clinical Medicine Insights: Therapeutics

Retricted access

Review article

First published 2012-6

Pralatrexate: A novel synthetic antifolate for relapsed or refractory peripheral T-cell lymphoma and other potential uses

John Hui, Eugene Przespo, Anjana Elefante

Journal of Oncology Pharmacy Practice

Retricted access

Review article

First published 2017-3

Belinostat for the treatment of relapsed or refractory peripheral T-cell lymphoma

Peter Campbell, Christan M Thomas

Journal of Oncology Pharmacy Practice

Free access

Review article

First published 2015-8

Belinostat in patients with refractory or relapsed peripheral T-cell lymphoma: a perspective review

Ahmed Sawas, Dejan Radeski, Owen A. O’Connor

Therapeutic Advances in Hematology

Free access

Review article

First published 2013-6

Novel therapies for peripheral T-cell lymphomas

Andrei Shustov

Therapeutic Advances in Hematology

Free access

Research article

First published 2012-8

Safety and efficacy of pralatrexate in the treatment of patients with relapsed or refractory peripheral T-cell lymphoma

Enrica Marchi, Owen A. O’Connor

Therapeutic Advances in Hematology

Retricted access

Case report

First published 2021-12

Duvelisib as bridge to allotransplantation in refractory peripheral T-cell lymphoma with T-follicular helper phenotype: case report

Ginevra Lolli, Beatrice Casadei, Cinzia Pellegrini [...]

Tumori Journal

Search results